Joel Moss
Impact in
- Physiology top 1%
- Calcium signaling and nucleotide metabolism
- Sarcoidosis and Beryllium Toxicity Research
- Endocrinology top 5%
- Escherichia coli research studies
Papers in
-
- Glycosylation and Glycoproteins Research 2
-
- Toxin Mechanisms and Immunotoxins 7
- Co-authors
- E L Jacobson (1 shared paper)Robert C. Benjamin (1 shared paper)Myron K. Jacobson (1 shared paper)Patrick W. Rankin (1 shared paper)Martha Vaughan (4 shared papers)Anh-Hue Thi Tu (1 shared paper)Barbara H. Iglewski (1 shared paper)S.J. Stanley (2 shared papers)
- Journals
- Biochemistry (4 papers)The Journal of Immunology (3 papers)Infection and Immunity (1 paper)American Journal of Clinical Nutrition (1 paper)Molecular Pharmacology (1 paper)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Joel Moss
26 papers receiving 946 citations
Peers
Comparison fields: 5 of 82
- Physiology 208
- Endocrinology 121
- Immunology 326
- Oncology 346
- Infectious Diseases 173
Countries citing papers authored by Joel Moss
This map shows the geographic impact of Joel Moss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Moss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Moss more than expected).
Fields of papers citing papers by Joel Moss
This network shows the impact of papers produced by Joel Moss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Moss. The network helps show where Joel Moss may publish in the future.
Co-authors
The 25 scholars most cited alongside Joel Moss, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 222 | |
| 2 | Bacterial toxins and virulence factors in disease | 1995 | 147 |
| 3 | 1988 | 121 | |
| 4 | Steroid-sparing effects of pentoxifylline in pulmonary sarcoidosis. | 2009 | 68 |
| 5 | 1992 | 62 | |
| 6 | 1986 | 60 | |
| 7 | 1996 | 44 | |
| 8 | 1988 | 43 | |
| 9 | 1996 | 42 | |
| 10 | 1994 | 33 | |
| 11 | 1994 | 22 | |
| 12 | 1995 | 18 | |
| 13 | 1989 | 16 | |
| 14 | 1990 | 16 | |
| 15 | Signal transduction by receptor-responsive guanyl nucleotide-binding proteins: modulation by bacterial toxin-catalyzed ADP-ribosylation. | 1987 | 8 |
| 16 | 1982 | 8 | |
| 17 | 1976 | 7 | |
| 18 | 1994 | 6 | |
| 19 | 2003 | 6 | |
| 20 | 1991 | 6 |
About Joel Moss
Joel Moss is a scholar working on Molecular Biology, Immunology, Oncology, Physiology and Cell Biology, having authored 26 papers that have together received 972 indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (7 papers), PARP inhibition in cancer therapy (6 papers), Calcium signaling and nucleotide metabolism (6 papers), Nitric Oxide and Endothelin Effects (3 papers), Cellular transport and secretion (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Physiology (208 citations), Endocrinology (121 citations), Immunology (326 citations), Oncology (346 citations) and Infectious Diseases (173 citations). Joel Moss has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include E L Jacobson, Robert C. Benjamin, Myron K. Jacobson, Patrick W. Rankin, Martha Vaughan, Anh-Hue Thi Tu, Barbara H. Iglewski, S.J. Stanley, Ian J. Okazaki and Jane L. Halpern. Their work appears in journals such as Biochemistry, The Journal of Immunology, Infection and Immunity, American Journal of Clinical Nutrition and Molecular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.